Annual CFI
-$836.00 K
+$2.04 M+70.89%
30 April 2024
Summary:
Champions Oncology annual cash flow from investing activities is currently -$836.00 thousand, with the most recent change of +$2.04 million (+70.89%) on 30 April 2024. During the last 3 years, it has risen by +$2.33 million (+73.62%). CSBR annual CFI is now -188.84% below its all-time high of $941.00 thousand, reached on 30 April 2010.CSBR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
-$111.00 K-100.00%
31 July 2024
Summary:
Champions Oncology quarterly cash flow from investing activities is currently $0.00, with the most recent change of -$111.00 thousand (-100.00%) on 31 July 2024. Over the past year, it has increased by +$153.00 thousand (+100.00%). CSBR quarterly CFI is now -100.00% below its all-time high of $973.00 thousand, reached on 31 July 2009.CSBR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$168.00 K
+$668.00 K+79.90%
31 July 2024
Summary:
Champions Oncology TTM cash flow from investing activities is currently -$168.00 thousand, with the most recent change of +$668.00 thousand (+79.90%) on 31 July 2024. Over the past year, it has increased by +$2.17 million (+92.81%). CSBR TTM CFI is now -117.85% below its all-time high of $941.00 thousand, reached on 30 April 2010.CSBR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.9% | +100.0% | +92.8% |
| 3 y3 years | +73.6% | +100.0% | +95.2% |
| 5 y5 years | -0.2% | -100.0% | +80.7% |
CSBR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +73.6% | -100.0% | +100.0% | at high | +95.2% |
| 5 y | 5 years | -0.2% | +73.6% | -100.0% | +100.0% | at high | +95.7% |
| alltime | all time | -188.8% | +73.6% | -100.0% | +100.0% | -117.8% | +95.7% |
Champions Oncology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $0.00(-100.0%) | -$168.00 K(-79.9%) |
| Apr 2024 | -$836.00 K(-70.9%) | $111.00 K(-188.1%) | -$836.00 K(-51.0%) |
| Jan 2024 | - | -$126.00 K(-17.6%) | -$1.71 M(-26.9%) |
| Oct 2023 | - | -$153.00 K(-77.1%) | -$2.33 M(-16.2%) |
| July 2023 | - | -$668.00 K(-12.1%) | -$2.79 M(-3.0%) |
| Apr 2023 | -$2.87 M(+20.5%) | -$760.00 K(+0.8%) | -$2.87 M(+9.7%) |
| Jan 2023 | - | -$754.00 K(+24.8%) | -$2.62 M(+15.4%) |
| Oct 2022 | - | -$604.00 K(-19.9%) | -$2.27 M(+1.7%) |
| July 2022 | - | -$754.00 K(+49.0%) | -$2.23 M(-6.4%) |
| Apr 2022 | -$2.38 M(-24.8%) | -$506.00 K(+24.9%) | -$2.38 M(-12.1%) |
| Jan 2022 | - | -$405.00 K(-28.4%) | -$2.71 M(-22.7%) |
| Oct 2021 | - | -$566.00 K(-37.6%) | -$3.51 M(+1.7%) |
| July 2021 | - | -$907.00 K(+8.8%) | -$3.45 M(+8.9%) |
| Apr 2021 | -$3.17 M(+42.7%) | -$834.00 K(-30.7%) | -$3.17 M(-17.9%) |
| Jan 2021 | - | -$1.20 M(+137.7%) | -$3.86 M(+36.5%) |
| Oct 2020 | - | -$506.00 K(-19.2%) | -$2.83 M(+35.0%) |
| July 2020 | - | -$626.00 K(-59.0%) | -$2.10 M(-5.5%) |
| Apr 2020 | -$2.22 M(+166.2%) | -$1.53 M(+793.0%) | -$2.22 M(+166.2%) |
| Jan 2020 | - | -$171.00 K(-175.3%) | -$834.00 K(-4.1%) |
| Oct 2019 | - | $227.00 K(-130.3%) | -$870.00 K(-36.6%) |
| July 2019 | - | -$749.00 K(+431.2%) | -$1.37 M(+64.5%) |
| Apr 2019 | -$834.00 K(-32.0%) | -$141.00 K(-31.9%) | -$834.00 K(-7.5%) |
| Jan 2019 | - | -$207.00 K(-24.7%) | -$902.00 K(+17.1%) |
| Oct 2018 | - | -$275.00 K(+30.3%) | -$770.00 K(+46.1%) |
| July 2018 | - | -$211.00 K(+1.0%) | -$527.00 K(-57.0%) |
| Apr 2018 | -$1.23 M(+60.1%) | -$209.00 K(+178.7%) | -$1.23 M(-23.5%) |
| Jan 2018 | - | -$75.00 K(+134.4%) | -$1.60 M(-4.5%) |
| Oct 2017 | - | -$32.00 K(-96.5%) | -$1.68 M(+1.1%) |
| July 2017 | - | -$910.00 K(+55.6%) | -$1.66 M(+116.6%) |
| Apr 2017 | -$766.00 K(+137.9%) | -$585.00 K(+287.4%) | -$766.00 K(+134.3%) |
| Jan 2017 | - | -$151.00 K(+1061.5%) | -$327.00 K(+6.2%) |
| Oct 2016 | - | -$13.00 K(-23.5%) | -$308.00 K(-0.6%) |
| July 2016 | - | -$17.00 K(-88.4%) | -$310.00 K(-3.7%) |
| Apr 2016 | -$322.00 K(+182.5%) | -$146.00 K(+10.6%) | -$322.00 K(+56.3%) |
| Jan 2016 | - | -$132.00 K(+780.0%) | -$206.00 K(+136.8%) |
| Oct 2015 | - | -$15.00 K(-48.3%) | -$87.00 K(-20.9%) |
| July 2015 | - | -$29.00 K(-3.3%) | -$110.00 K(-3.5%) |
| Apr 2015 | -$114.00 K(-51.3%) | -$30.00 K(+130.8%) | -$114.00 K(-26.0%) |
| Jan 2015 | - | -$13.00 K(-65.8%) | -$154.00 K(-32.8%) |
| Oct 2014 | - | -$38.00 K(+15.2%) | -$229.00 K(+0.9%) |
| July 2014 | - | -$33.00 K(-52.9%) | -$227.00 K(-3.0%) |
| Apr 2014 | -$234.00 K(+310.5%) | -$70.00 K(-20.5%) | -$234.00 K(+25.8%) |
| Jan 2014 | - | -$88.00 K(+144.4%) | -$186.00 K(+77.1%) |
| Oct 2013 | - | -$36.00 K(-10.0%) | -$105.00 K(+34.6%) |
| July 2013 | - | -$40.00 K(+81.8%) | -$78.00 K(+36.8%) |
| Apr 2013 | -$57.00 K(-89.0%) | -$22.00 K(+214.3%) | -$57.00 K(-68.9%) |
| Jan 2013 | - | -$7000.00(-22.2%) | -$183.00 K(-52.7%) |
| Oct 2012 | - | -$9000.00(-52.6%) | -$387.00 K(-12.6%) |
| July 2012 | - | -$19.00 K(-87.2%) | -$443.00 K(-14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2012 | -$519.00 K(+517.9%) | -$148.00 K(-29.9%) | -$519.00 K(+27.2%) |
| Jan 2012 | - | -$211.00 K(+224.6%) | -$408.00 K(+86.3%) |
| Oct 2011 | - | -$65.00 K(-31.6%) | -$219.00 K(+37.7%) |
| July 2011 | - | -$95.00 K(+156.8%) | -$159.00 K(+89.3%) |
| Apr 2011 | -$84.00 K(-108.9%) | -$37.00 K(+68.2%) | -$84.00 K(+1.2%) |
| Jan 2011 | - | -$22.00 K(+340.0%) | -$83.00 K(+20.3%) |
| Oct 2010 | - | -$5000.00(-75.0%) | -$69.00 K(+32.7%) |
| July 2010 | - | -$20.00 K(-44.4%) | -$52.00 K(-105.5%) |
| Apr 2010 | $941.00 K(-181.8%) | -$36.00 K(+350.0%) | $941.00 K(+8.2%) |
| Jan 2010 | - | -$8000.00(-166.7%) | $870.00 K(-658.1%) |
| Oct 2009 | - | $12.00 K(-98.8%) | -$155.90 K(-4.4%) |
| July 2009 | - | $973.00 K(-1009.3%) | -$163.00 K(-85.8%) |
| Apr 2009 | -$1.15 M(-371.2%) | -$107.00 K(-89.7%) | -$1.15 M(+85.8%) |
| Jan 2009 | - | -$1.03 M(<-9900.0%) | -$619.00 K(-249.2%) |
| Oct 2008 | - | $4900.00(-135.0%) | $414.90 K(+1.2%) |
| July 2008 | - | -$14.00 K(-103.3%) | $410.00 K(-3.3%) |
| Apr 2008 | $424.00 K(>+9900.0%) | $424.00 K(>+9900.0%) | $424.00 K(>+9900.0%) |
| Jan 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2007 | - | $0.00(0.0%) | $0.00(-100.0%) |
| July 2007 | - | $0.00(0.0%) | -$18.90 K(<-9900.0%) |
| Apr 2007 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2007 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Oct 2006 | - | -$18.90 K(-200.0%) | $0.00(-100.0%) |
| July 2006 | - | $18.90 K(>+9900.0%) | $18.90 K(+89.0%) |
| Apr 2006 | $10.00 K(>+9900.0%) | $0.00(0.0%) | $10.00 K(0.0%) |
| Jan 2006 | - | $0.00(0.0%) | $10.00 K(0.0%) |
| Oct 2005 | - | $0.00(-100.0%) | $10.00 K(0.0%) |
| July 2005 | - | $10.00 K(>+9900.0%) | $10.00 K(>+9900.0%) |
| Apr 2005 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2004 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Apr 2004 | -$2900.00(-68.1%) | $0.00(0.0%) | -$2900.00(-52.5%) |
| Jan 2004 | - | $0.00(0.0%) | -$6100.00(-19.7%) |
| Oct 2003 | - | $0.00(-100.0%) | -$7600.00(-35.0%) |
| July 2003 | - | -$2900.00(-9.4%) | -$11.70 K(+28.6%) |
| Apr 2003 | -$9100.00(-36.8%) | -$3200.00(+113.3%) | -$9100.00(-72.4%) |
| Jan 2003 | - | -$1500.00(-63.4%) | -$33.00 K(+81.3%) |
| Oct 2002 | - | -$4100.00(+1266.7%) | -$18.20 K(+23.8%) |
| July 2002 | - | -$300.00(-98.9%) | -$14.70 K(+2.1%) |
| Apr 2002 | -$14.40 K(-94.8%) | -$27.10 K(-303.8%) | -$14.40 K(-93.7%) |
| Jan 2002 | - | $13.30 K(-2316.7%) | -$229.40 K(-8.1%) |
| Oct 2001 | - | -$600.00(<-9900.0%) | -$249.60 K(-4.2%) |
| July 2001 | - | $0.00(-100.0%) | -$260.60 K(-5.5%) |
| Apr 2001 | -$275.80 K(+148.9%) | -$242.10 K(+3408.7%) | -$275.80 K(+718.4%) |
| Jan 2001 | - | -$6900.00(-40.5%) | -$33.70 K(+25.7%) |
| Oct 2000 | - | -$11.60 K(-23.7%) | -$26.80 K(+76.3%) |
| July 2000 | - | -$15.20 K | -$15.20 K |
| Apr 2000 | -$110.80 K | - | - |
FAQ
- What is Champions Oncology annual cash flow from investing activities?
- What is the all time high annual CFI for Champions Oncology?
- What is Champions Oncology annual CFI year-on-year change?
- What is Champions Oncology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Champions Oncology?
- What is Champions Oncology quarterly CFI year-on-year change?
- What is Champions Oncology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Champions Oncology?
- What is Champions Oncology TTM CFI year-on-year change?
What is Champions Oncology annual cash flow from investing activities?
The current annual CFI of CSBR is -$836.00 K
What is the all time high annual CFI for Champions Oncology?
Champions Oncology all-time high annual cash flow from investing activities is $941.00 K
What is Champions Oncology annual CFI year-on-year change?
Over the past year, CSBR annual cash flow from investing activities has changed by +$2.04 M (+70.89%)
What is Champions Oncology quarterly cash flow from investing activities?
The current quarterly CFI of CSBR is $0.00
What is the all time high quarterly CFI for Champions Oncology?
Champions Oncology all-time high quarterly cash flow from investing activities is $973.00 K
What is Champions Oncology quarterly CFI year-on-year change?
Over the past year, CSBR quarterly cash flow from investing activities has changed by +$153.00 K (+100.00%)
What is Champions Oncology TTM cash flow from investing activities?
The current TTM CFI of CSBR is -$168.00 K
What is the all time high TTM CFI for Champions Oncology?
Champions Oncology all-time high TTM cash flow from investing activities is $941.00 K
What is Champions Oncology TTM CFI year-on-year change?
Over the past year, CSBR TTM cash flow from investing activities has changed by +$2.17 M (+92.81%)